Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
NCT06303921
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Tauopathies
Interventions
DRUG:
11C-M503 PET
DIAGNOSTIC_TEST:
Brain MRI
DIAGNOSTIC_TEST:
Amyloid PET
BEHAVIORAL:
Neurological assessments
Sponsor
University of Pennsylvania